Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus. | Curr Microbiol | 2021 | 34550435 | PubTator, text mining | PubMed |
| Proteome-Wide Characterizations of N6-Methyl-Adenosine Triphosphate- and N6-Furfuryl-Adenosine Triphosphate-Binding Capabilities of Kinases. | Anal Chem | 2021 | 34549933 | PubTator, text mining | PubMed |
| The circular RNA circBCL2L1 regulates innate immune responses via microRNA-mediated downregulation of TRAF6 in teleost fish. | J Biol Chem | 2021 | 34536420 | PubTator, text mining | PubMed |
| Role of competitive endogenous RNA networks in the pathogenesis of coronary artery disease. | Ann Transl Med | 2021 | 34532371 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking-Based Prediction of the Mechanism of Qianghuo Shengshi Decoction against Rheumatoid Arthritis. | Biomed Res Int | 2021 | 34527739 | PubTator, text mining | PubMed |
| Stimulus-specific responses in innate immunity: Multilayered regulatory circuits. | Immunity | 2021 | 34525335 | PubTator, text mining | PubMed |
| Foot-and-Mouth Disease Virus VP3 Protein Acts as a Critical Proinflammatory Factor by Promoting Toll-Like Receptor 4-Mediated Signaling. | J Virol | 2021 | 34524915 | PubTator, text mining | PubMed |
| Therapeutic targeting of the inflammasome in myeloid malignancies. | Blood Cancer J | 2021 | 34521810 | PubTator, text mining | PubMed |
| Immune-mediated inflammatory disease therapeutics: past, present and future. | Nat Rev Immunol | 2021 | 34518662 | PubTator, text mining | PubMed |
| The expression and activity of Toll-like receptors in the preimplantation human embryo suggest a new role for innate immunity. | Hum Reprod | 2021 | 34517414 | PubTator, text mining | PubMed |
| Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2. | PLoS Comput Biol | 2021 | 34516563 | PubTator, text mining | PubMed |
| An integrated analysis of mRNAs, lncRNAs, and miRNAs based on weighted gene co-expression network analysis involved in bovine endometritis. | Sci Rep | 2021 | 34508138 | PubTator, text mining | PubMed |
| Exosome: Function and Application in Inflammatory Bone Diseases. | Oxid Med Cell Longev | 2021 | 34504641 | PubTator, text mining | PubMed |
| Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes. | Genome Med | 2021 | 34503567 | PubTator, text mining | PubMed |
| Imidazopyridazine Acetylcholinesterase Inhibitors Display Potent Anti-Proliferative Effects in the Human Neuroblastoma Cell-Line, IMR-32. | Molecules | 2021 | 34500749 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| ZDHHC11 Positively Regulates NF-κB Activation by Enhancing TRAF6 Oligomerization. | Front Cell Dev Biol | 2021 | 34490261 | PubTator, text mining | PubMed |
| Influence of Exercise on Exhausted and Senescent T Cells: A Systematic Review. | Front Physiol | 2021 | 34489717 | PubTator, text mining | PubMed |
| Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. | PLoS Pathog | 2021 | 34473805 | PubTator, text mining | PubMed |
| Mitofusin 2 Deficiency Causes Pro-Inflammatory Effects in Human Primary Macrophages. | Front Immunol | 2021 | 34456930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=57